Trading Members of the Exchange are hereby informed that effective from May 19, 2026, the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of 'MT' Group Securities. For further details please refer to the notice no. 20260518- dated May 18, 2026.